Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
Clinical trial NCT02317471 · UNKNOWN
Trial details
- NCT number
- NCT02317471
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.